Harrow Health 8625 Stock Probability of Future Stock Price Finishing Over 25.26
| HROWL Stock | USD 25.26 0.05 0.20% |
Harrow |
Harrow Health Target Price Odds to finish over 25.26
The tendency of Harrow Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 25.26 | 90 days | 25.26 | about 50.0 |
Based on a normal probability distribution, the odds of Harrow Health to move above the current price in 90 days from now is about 50.0 (This Harrow Health 8625 probability density function shows the probability of Harrow Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon Harrow Health 8625 has a beta of -0.0064. This usually indicates as returns on the benchmark increase, returns on holding Harrow Health are expected to decrease at a much lower rate. During a bear market, however, Harrow Health 8625 is likely to outperform the market. Additionally Harrow Health 8625 has an alpha of 0.0057, implying that it can generate a 0.005702 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Harrow Health Price Density |
| Price |
Predictive Modules for Harrow Health
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Harrow Health 8625. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Harrow Health's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Harrow Health Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Harrow Health is not an exception. The market had few large corrections towards the Harrow Health's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Harrow Health 8625, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Harrow Health within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.01 | |
β | Beta against Dow Jones | -0.0064 | |
σ | Overall volatility | 0.12 | |
Ir | Information ratio | -0.05 |
Harrow Health Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Harrow Health for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Harrow Health 8625 can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Harrow Health 8625 has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 130.19 M. Net Loss for the year was (24.41 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Harrow Health 8625 has a frail financial position based on the latest SEC disclosures | |
| Latest headline from MacroaxisInsider: Acquisition by Baum Mark L of 180000 shares of Harrow Health at 8.99 subject to Rule 16b-3 |
Harrow Health Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Harrow Stock often depends not only on the future outlook of the current and potential Harrow Health's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Harrow Health's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 32.6 M | |
| Cash And Short Term Investments | 82.8 M |
Harrow Health Technical Analysis
Harrow Health's future price can be derived by breaking down and analyzing its technical indicators over time. Harrow Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Harrow Health 8625. In general, you should focus on analyzing Harrow Stock price patterns and their correlations with different microeconomic environments and drivers.
Harrow Health Predictive Forecast Models
Harrow Health's time-series forecasting models is one of many Harrow Health's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Harrow Health's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Harrow Health 8625
Checking the ongoing alerts about Harrow Health for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Harrow Health 8625 help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Harrow Health 8625 has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 130.19 M. Net Loss for the year was (24.41 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Harrow Health 8625 has a frail financial position based on the latest SEC disclosures | |
| Latest headline from MacroaxisInsider: Acquisition by Baum Mark L of 180000 shares of Harrow Health at 8.99 subject to Rule 16b-3 |
Check out Harrow Health Backtesting, Harrow Health Valuation, Harrow Health Correlation, Harrow Health Hype Analysis, Harrow Health Volatility, Harrow Health History as well as Harrow Health Performance. For more information on how to buy Harrow Stock please use our How to buy in Harrow Stock guide.You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Harrow Health. If investors know Harrow will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Harrow Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Return On Equity 0.4484 |
The market value of Harrow Health 8625 is measured differently than its book value, which is the value of Harrow that is recorded on the company's balance sheet. Investors also form their own opinion of Harrow Health's value that differs from its market value or its book value, called intrinsic value, which is Harrow Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Harrow Health's market value can be influenced by many factors that don't directly affect Harrow Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Harrow Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Harrow Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harrow Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.